Education
About Us
Working with TipRanks
Follow Us
Daniel Gordon Kirby Insider Profile
4 Followers
Daniel Gordon Kirby, CCO at Iovance Biotherapeutics, holds 30.00K shares in Iovance Biotherapeutics (Ticker: IOVA). Most recently, Daniel Gordon Kirby Bought $30,000 shares of Iovance Biotherapeutics on Jun 06, 2025 for an estimated value of 55.20K.
Daniel Gordon Kirby has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Daniel Gordon Kirby's holdings
Insider Roles
CCO
Roles that Daniel Gordon Kirby holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Daniel Gordon Kirby
Daniel Gordon Kirby's Trading History
List of latest transactions for each holding click on a transaction to see Daniel Gordon Kirby's performance on stock
You May Also Like
Daniel Gordon Kirby insider profile FAQ
What is the percentage of profitable transactions made by Daniel Gordon Kirby?
The percentage of profitable transactions made by Daniel Gordon Kirby is ―.
What is the average return per transaction made by Daniel Gordon Kirby?
The average return per transaction made by Daniel Gordon Kirby is ―.
What stocks does Daniel Gordon Kirby hold?
Daniel Gordon Kirby holds: IOVA stocks.
What was Daniel Gordon Kirby’s latest transaction?
Daniel Gordon Kirby latest transaction was an Informative Buy of $55.20K.
What was Daniel Gordon Kirby's most profitable transaction?
Daniel Gordon Kirby’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Daniel Gordon Kirby's role in Iovance Biotherapeutics?
Daniel Gordon Kirby's role in Iovance Biotherapeutics is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.